Cita APA (7a ed.)
Choi, H., Minn, Y., Kang, S., & Han, S. (Dec 1, 2025). Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment (SB‐DEX): A multicenter, prospective, comparative, randomized, independent rater‐blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairment (ClinicalTrials.gov ID NCT06264557). Alzheimer's & Dementia. https://doi.org/10.1002/alz70859_102394
Cita Chicago Style (17a ed.)
Choi, Hojin, Yangki Minn, Sungmin Kang, y Seunghyun Han. "Cognitive Therapy Software for Improving Cognitive Function for Patients with Mild Cognitive Impairment (SB‐DEX): A Multicenter, Prospective, Comparative, Randomized, Independent Rater‐blind, Superiority, Pivotal Clinical Trial to Compare the Safety and Efficacy of the Cognitive Therapy Software ‘SUPERBRAIN DEX’ for Improving Cognitive Function with a Control Group for Patients with Mild Cognitive Impairment (ClinicalTrials.gov ID NCT06264557)." Alzheimer's & Dementia Dec 1, 2025. https://doi.org/10.1002/alz70859_102394.
Cita MLA (9a ed.)
Choi, Hojin, et al. "Cognitive Therapy Software for Improving Cognitive Function for Patients with Mild Cognitive Impairment (SB‐DEX): A Multicenter, Prospective, Comparative, Randomized, Independent Rater‐blind, Superiority, Pivotal Clinical Trial to Compare the Safety and Efficacy of the Cognitive Therapy Software ‘SUPERBRAIN DEX’ for Improving Cognitive Function with a Control Group for Patients with Mild Cognitive Impairment (ClinicalTrials.gov ID NCT06264557)." Alzheimer's & Dementia, Dec 1, 2025, https://doi.org/10.1002/alz70859_102394.
Precaución: Estas citas no son 100% exactas.